Site Search

Share

X

Search Results

Gov. Moore Approves Legislation to Expand Access to Biomarker Testing

... Gov. Wes Moore will be signing HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at 12:00pm in the State ... champions who saw HB 1217 / SB 805 to the finish line. For more information on precision medicine, cancer biomarkers, current barriers to biomarker testing and ACS CAN’s policy recommendations, visit:  www.fightcancer.org/biomarkers . ###  About ACS CAN The American Cancer Society ...

Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing

Pharmacogenomic (PGx) testing (also known as pharmacogenomic biomarker testing) is a component of precision medicine that involves examining a patient’s inherited genes to detect variations that may impact the way a ... treatment given to patients with the same disease can produce different responses based on each person's inherited genes. Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing ...

Bill Increasing Access to Biomarker Testing for Certain Coloradans Becomes Law

... law during a ceremony at the Governor’s Mansion on Monday afternoon, ensuring more Colorado patients with private insurance have coverage for biomarker testing . The American Cancer Society Cancer Action Network (ACS CAN) recognizes the signing of the bill as a positive first step to increasing access to biomarker testing to connect patients with the right treatment at the right time. During Monday’s ceremony, Governor Polis was surrounded by ...

Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment

... to support ACS CAN’s advocacy work at all levels of government. Fielded September 12-25, 2023, our latest survey explores experiences with biomarker testing. The web-based survey was conducted among 1,222n cancer patients and survivors nationwide who have been diagnosed with or treated for cancer in the last seven years. Summary of Findings Higher Income and Education Groups are Most Likely to Report Having and Asking for Biomarker Testing About half (49%) of those surveyed have had biomarker testing for their cancer, while 29% say they have not and 22% are unsure. ...

Lamont Signs into Law Legislation to Remove Barriers to Biomarker Testing

HARTFORD –   Yesterday, Gov. Ned Lamont signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing . This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease.      The ...

New York State Senate Votes to Remove Barriers to Biomarker Testing

ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. This legislative victory came several hours after the ... Cancer Society Cancer Action Network (ACS CAN) hosted cancer patients and survivors at the Capitol to honor National Cancer Survivors Day.   Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, ...

ACS CAN Calls for Expanded Access to Biomarker Testing in Washington

... convene for the new session, it is crucial for them to prioritize cancer patients and cancer care by assuring all residents have ready access to biomarker testing. "Access to biomarker testing is about identifying the most effective treatment—which can save lives. It is the pathway to precision medicine, which can make ...

Legislation to Increase Access to Biomarker Testing Receives Favorable Committee Report

BOSTON - Today, the Joint Committee on Financial Services reported legislation to expand access to guideline indicated biomarker testing, favorably out of committee. The bills, S.689 and H.1074,  An Act relative to patient access to biomarker testing to provide appropriate therapy , sponsored by Senator Susan Moran and Representative Meg Kilcoyne, would increase access to ...

PA House Insurance Committee Votes to Remove Barriers to Biomarker Testing

Today, the House Insurance Committee voted to improve Pennsylvanians’ access to biomarker testing, advancing House Bill 1754 out of committee unanimously. Championed by Representatives Kyle Mullins and Minority Leader Bryan Cutler, the proposal would ensure biomarker testing is a covered benefit in Pennsylvania-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it ...

Mainers Won’t See Increased Access to Biomarker Testing This Legislative Session

... This legislation, which passed both House and Senate chambers earlier this month with broad bipartisan support, would have increased access to biomarker testing  for Mainers who need it, ensuring they can receive the right treatment at the right time for their disease. The following can be ... Maine director of government relations for the American Cancer Society Cancer Action Network (ACS CAN): “We are disappointed that the biomarker testing coverage legislation will not be signed into law. On behalf of the cancer patients, survivors and caregivers we represent across ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy